ALX Oncology Holdings Inc. (NASDAQ:ALXO) Q2 2025 Earnings Call Transcript August 12, 2025
ALX Oncology Holdings Inc. misses on earnings expectations. Reported EPS is $-0.49 EPS, expectations were $-0.46.
Jason W. Lettmann: Thanks, everyone, and welcome to our Q2 2025 results. I appreciate everybody spending some time this afternoon with us and looking forward to this update. On Slide 2, before we start our presentation, as housekeeping, here are our forward-looking statements for your...
